Insights - Cempra, Inc. (CEMP) enrolled patients in SOLITAIRE-Oral, a phase 3 trial of lead antibiotic solithromycin, slightly faster than expected, announcing completion on Thursday that puts a … Continue Reading
Read nowInsights - Merrimack Pharmaceuticals (NASDAQ:MACK) and Baxter (NYSE:BAX) have climbed into bed on MM-398, Merrimack’s drug candidate for the treatment of metastatic pancreatic cancer, in a licensing deal worth … Continue Reading
Read nowInsights - Titan Pharmaceuticals (TTNP) announced on Tuesday that enrollment in a final phase 3 trial of Probuphine has reached the halfway mark, and that the company continues … Continue Reading
Read nowRecap - Auxilium Pharmaceuticals (AUXL) was approached by Endo Pharmaceuticals (ENDP) this week in a $2.2 billion unsolicited acquisition attempt. The stock and cash deal would represent … Continue Reading
Read nowRecap - A dual event in the obesity space this week, the U.S. FDA approved Orexigen Therapeutics’ (OREX) weight loss pill Contrave just one day before an … Continue Reading
Read nowRecap - Six weeks after Federal Reserve Chairwoman Janet Yellen called biotechnology valuations “substantially stretched” the NASDAQ Biotechnology Index (IBB) is setting new records right alongside the S&P 500. It’s … Continue Reading
Read now
